Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts (2019) Harrach S, Barz V, Pap T, Pavenstaedt H, Schlatter E, Edemir B, Distler J, et al. Journal article PASI <= 2 corresponds to PASI 90, irrespective of baseline severity: A post-hoc analysis of the PRIME-study (2017) Reich K, Sieder C, Bachhuber T, Melzer N, Sticherling M Conference contribution Ex vivo expanded NK cells up-regulate natural cytotoxicity receptors able to mediate autologous melanoma cell killing (2017) Roessner S, Gross S, Karg M, Hamann A, Campana D, Schuler-Thurner B, Bosch J, et al. Conference contribution Role of the ceramide-CD300f interaction in gram-negative bacterial skin infections (2017) Maehara A, Kaitani A, Izawa K, Shiba E, Nagamine M, Takamori A, Isobe M, et al. Journal article Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016 (2017) Schmidt E, Spindler V, Eming R, Amagai M, Antonicelli F, Baines JF, Belheouane M, et al. Journal article, Report Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry (2017) Gassenmaier M, Eigentler TK, Keim U, Goebeler M, Fiedler E, Schuler G, Leiter U, et al. Journal article Antigen targeting of Fc-receptors induces strong T cell responses in vivo independent of ITAM signalling (2016) Lehmann C, Baranska A, Heidkamp GF, Kiessling M, Soulat D, Krug A, Ravetch JV, et al. Journal article gamma/delta T cells RNA-transfected with a T-cell receptor and a chimeric antigen receptor specific for melanoma (2016) Harrer D, Simon B, Schuler G, Uslu U, Hoyer S, Dörrie J, Schaft N Conference contribution A web-based comprehensive map including regulatory pathways subverted in melanoma that can be visualized, browsed and used for analysing cell line and patient high through put data (2016) Dreyer F, Cantone M, Eberhardt M, Schuler G, Vera J Conference contribution Combining a CAR and a TCR to generate T cells expressing two additional receptors (TETARs) for melanoma immunotherapy (2016) Uslu U, Gerer K, Hoyer S, Schuler G, Dörrie J, Schaft N Conference contribution